```html

Extravasation (Fluid Leakage): What It Is, Why It Happens, and How to Manage It

What is Extravasation (fluid leakage)?

Extravasation is the accidental leakage of fluid—often a medication, contrast dye, or blood—out of a blood vessel or a catheter and into the surrounding tissue. The term comes from the Latin extra‑ (outside) and vasare (to pour). While a small amount of fluid that escapes into tissue is usually harmless, larger volumes or certain substances (e.g., vesicant chemotherapy agents) can cause pain, swelling, skin damage, and even tissue necrosis.

Extravasation can occur with intravenous (IV) lines, central venous catheters, peripheral inserted central catheters (PICC), and even with subcutaneous infusions. The condition is a medical emergency when the leaked fluid is a vesicant (a drug that can blister or destroy tissue) or when the leak is large enough to compromise circulation.

Understanding the mechanisms, risk factors, and early signs of extravasation helps patients and clinicians intervene promptly and limit complications.

Common Causes

Extravasation can be triggered by a variety of medical procedures, medications, or underlying conditions. Below are the most frequent contributors:

• Vesicant chemotherapy agents (e.g., doxorubicin, vincristine, cisplatin) – these drugs can cause severe tissue injury if they escape the vein.
• Contrast media used for CT, MRI, or angiography – especially high‑osmolality agents.
Intravenous antibiotics such as vancomycin or cefazolin when given in high concentrations.
• Vasopressors and inotropes (e.g., norepinephrine, dopamine) – these potent drugs can cause vasoconstriction and ischemia if they extravasate.
• Peripheral IV catheters that are poorly placed or become dislodged.
• Central venous catheters (including PICC lines) that perforate the vessel wall.
• Subcutaneous insulin or heparin infusions administered via infusion pumps.
• Blood transfusions when the line is compromised.
• Radiation therapy ports that inadvertently infiltrate surrounding tissue.
• Trauma or surgical injury to a vessel that later leaks during postoperative care.

Associated Symptoms

Symptoms vary with the type of fluid, volume leaked, and location of the infiltration. Commonly observed signs include:

• Localized swelling or edema that develops rapidly.
• Pain or burning sensation at the infusion site—often described as “tightness.”
• Redness (erythema) that may progress to a bluish or purple hue.
• Heat or warmth over the area.
• Taut, glossy skin that may develop blisters or “vesicles.”
• Loss of sensation or tingling (paresthesia) if nerves are involved.
• Decreased range of motion in a nearby joint.
• In severe cases, a firm, indurated mass that does not compress (suggesting tissue necrosis).

When to See a Doctor

Prompt medical evaluation is crucial. Seek professional help if you notice any of the following:

• Sudden swelling or pain that worsens within minutes of an infusion.
• Skin turns pink, purple, or develops blisters.
• Persistent burning or tingling that does not improve after the line is stopped.
• Loss of movement or strength in the affected limb.
• Fever, chills, or signs of infection (red streaks, pus).
• Any suspicion that a vesicant chemotherapy drug has leaked.
• Signs of compartment syndrome – severe pain that is out of proportion to the swelling, pain with passive stretch, or numbness.

For patients receiving chemotherapy or other known vesicants, call the oncology infusion center immediately if any signs appear, even if they seem mild.

Diagnosis

Clinicians combine a focused history, physical exam, and sometimes imaging to confirm extravasation and assess severity.

History & Physical Examination

• Identify the drug, concentration, and infusion rate.
• Document the time of onset and progression of symptoms.
• Examine the site for swelling, color changes, temperature, and tenderness.

Imaging (when needed)

• Ultrasound – detects fluid collections, helps differentiate simple edema from a hematoma.
• Contrast‑enhanced CT or MRI – useful if the extravasated agent is contrast media and the extent needs mapping.
• Fluorescence or radio‑labeled tracer studies – occasionally employed in research settings to visualize drug spread.

Laboratory Tests

• Complete blood count and inflammatory markers if infection is suspected.
• Renal function tests when nephrotoxic agents (e.g., cisplatin) have leaked.

Treatment Options

Management depends on the type of fluid, volume leaked, and time since extravasation. Prompt action can limit tissue damage.

Immediate First‑Aid (to be performed by healthcare staff)

1. Stop the infusion immediately.
2. Leave the catheter in place (do not remove) to attempt aspiration of the extravasated fluid.
3. Elevate the affected limb above heart level to reduce swelling.
4. Apply a cold compress for vesicants (e.g., chemotherapy) to cause vasoconstriction and limit diffusion – 15 minutes on, 15 minutes off.
5. Use a warm compress for non‑vesicant drugs (e.g., antibiotics, contrast) to promote vasodilation and absorption.
6. Consider pharmacologic antidotes when available (see table below).

Antidotes for Specific Vesicants

Drug	Antidote/Intervention	Evidence
Doxorubicin, Daunorubicin	Dexrazoxane (intravenous, 1000 mg/m²) within 6 h	NIH, 2022
Vincristine, Vinblastine	Hyaluronidase (1500 U intradermally) + warm compress	Cleveland Clinic, 2021
Mitomycin C	Thiosulfate (10 g IV) within 6 h	Mayo Clinic, 2020

Medical Management

• Pharmacologic pain control – acetaminophen, NSAIDs (if no contraindication), or short courses of opioids for severe pain.
• Topical agents – Aloe vera gel or sterile hydrogel dressings to maintain a moist environment and support healing.
• Wound care – If skin breakdown occurs, debridement and appropriate dressings are required.
• Physical therapy – Early gentle range‑of‑motion exercises prevent joint stiffness when swelling subsides.
• Surgical consultation – Indicated for compartment syndrome, extensive necrosis, or when conservative measures fail.

Home Care (after discharge)

1. Continue limb elevation whenever possible.
2. Apply the prescribed compress (cold or warm) for 20 minutes, 3‑4 times daily.
3. Monitor the site for increasing redness, swelling, or drainage.
4. Keep the area clean and covered with a sterile, non‑adhesive dressing.
5. Take prescribed analgesics as directed and avoid tight clothing or compressive wraps.
6. Follow up with your infusion team or wound‑care nurse within 48–72 hours.

Prevention Tips

Most extravasations are preventable with proper technique and vigilance:

• Choose the right vein – Larger, straight veins (e.g., forearm) reduce the risk compared with small or tortuous veins.
• Use appropriate catheters – Smaller gauge (e.g., 22‑gauge) for non‑vesicants; larger, secure catheters for vesicants.
• Secure the line with sterile adhesive devices to prevent movement.
• Regularly inspect the site during infusion—every 5–15 minutes for vesicants, every 30 minutes for routine fluids.
• Limit infusion pressure – Use infusion pumps with pressure alarms and avoid “push‑hard” manual boluses.
• Educate patients and caregivers on early signs of extravasation and encourage them to speak up immediately.
• Pre‑treat high‑risk skin with a barrier cream or protective dressing if the skin is fragile (e.g., elderly, steroid‑treated).
• Document catheter length and insertion depth to reduce the chance of tip migration.
• Follow manufacturer guidelines for each drug, especially vesicants that require diluted concentrations or specific infusion rates.

Emergency Warning Signs

These signs require immediate emergency department evaluation. Delay can result in permanent tissue loss, functional impairment, or systemic toxicity.

---

Sources: Mayo Clinic, CDC, NIH, WHO, Cleveland Clinic, peer‑reviewed oncology nursing journals (2020‑2023). All information is for educational purposes and does not replace personalized medical advice.

```